Antitumor Activity of Lurbinectedin in Second-Line Small Cell Lung Cancer Patients Who Are Candidates for Re-Challenge with the First-Line Treatment.
Lung Cancer（2020）
关键词
Lurbinectedin,Chemotherapy-free interval,Platinum re-challenge,NCCN guidelines
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要